The Food and Drug Administration’s approval on Friday of two groundbreaking gene therapy treatments for sickle cell disease has brought a rare moment of hope and celebration to people with the agonizing blood disorder.But there is no clear path for the new therapies — one-time treatments so effective in clinical trials that they have been…
